BRPI0410558A - processo para a preparação de emulsões oleosas isotÈnicas, emulsão oleosa isotÈnica, uso da mesma, e, processos para reposição de hormÈnio em bebês prematuros, e para o tratamento de danos neurológicos após derrames - Google Patents
processo para a preparação de emulsões oleosas isotÈnicas, emulsão oleosa isotÈnica, uso da mesma, e, processos para reposição de hormÈnio em bebês prematuros, e para o tratamento de danos neurológicos após derramesInfo
- Publication number
- BRPI0410558A BRPI0410558A BRPI0410558-3A BRPI0410558A BRPI0410558A BR PI0410558 A BRPI0410558 A BR PI0410558A BR PI0410558 A BRPI0410558 A BR PI0410558A BR PI0410558 A BRPI0410558 A BR PI0410558A
- Authority
- BR
- Brazil
- Prior art keywords
- isotonic
- oily
- hormone replacement
- processes
- preparation
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 239000000839 emulsion Substances 0.000 title abstract 3
- 239000005556 hormone Substances 0.000 title abstract 3
- 229940088597 hormone Drugs 0.000 title abstract 3
- 230000000926 neurological effect Effects 0.000 title 1
- 230000002028 premature Effects 0.000 title 1
- 230000000694 effects Effects 0.000 abstract 2
- 239000012071 phase Substances 0.000 abstract 2
- 239000000583 progesterone congener Substances 0.000 abstract 2
- 239000008346 aqueous phase Substances 0.000 abstract 1
- 230000002490 cerebral effect Effects 0.000 abstract 1
- 230000001966 cerebroprotective effect Effects 0.000 abstract 1
- 239000003995 emulsifying agent Substances 0.000 abstract 1
- 230000001804 emulsifying effect Effects 0.000 abstract 1
- 229940011871 estrogen Drugs 0.000 abstract 1
- 239000000262 estrogen Substances 0.000 abstract 1
- 238000001990 intravenous administration Methods 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 210000002569 neuron Anatomy 0.000 abstract 1
- 230000000324 neuroprotective effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Abstract
"PROCESSO PARA A PREPARAçãO DE EMULSõES OLEOSAS ISOTÈNICAS, EMULSãO OLEOSA ISOTÈNICA, USO DA MESMA, E, PROCESSOS PARA REPOSIçãO DE HORMÈNIO EM BEBêS PREMATUROS, E PARA O TRATAMENTO DE DANOS NEUROLóGICOS APóS DERRAMES". A invenção refere-se a um processo para a produção de emulsões oleosas (emulsões de lipídio) que contém hormónio, a uma emulsão oleosa isotónica que pode ser obtida pelo dito processo e ao uso da dita emulsão para a produção de um medicamento para administração intravenosa, em particular, para reposição pós-parto de hormónio em bebês prematuros e para o tratamento de danos neurológicos após isquemia cerebral.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03013790A EP1488785A1 (de) | 2003-06-18 | 2003-06-18 | Ölemulsion zur postnatalen Hormonsubstitution |
| PCT/EP2004/051114 WO2004110402A1 (de) | 2003-06-18 | 2004-06-15 | Ölemulsion zur postnatalen hormonsubstitution |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0410558A true BRPI0410558A (pt) | 2006-06-20 |
Family
ID=33395816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0410558-3A BRPI0410558A (pt) | 2003-06-18 | 2004-06-15 | processo para a preparação de emulsões oleosas isotÈnicas, emulsão oleosa isotÈnica, uso da mesma, e, processos para reposição de hormÈnio em bebês prematuros, e para o tratamento de danos neurológicos após derrames |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20070071777A1 (pt) |
| EP (2) | EP1488785A1 (pt) |
| JP (1) | JP2006527736A (pt) |
| CN (1) | CN1809339B (pt) |
| AT (1) | ATE359061T1 (pt) |
| BR (1) | BRPI0410558A (pt) |
| CA (1) | CA2526567A1 (pt) |
| DE (1) | DE502004003483D1 (pt) |
| ES (1) | ES2281813T3 (pt) |
| MX (1) | MXPA05012411A (pt) |
| PL (1) | PL1633325T3 (pt) |
| PT (1) | PT1633325E (pt) |
| RU (1) | RU2318494C2 (pt) |
| WO (1) | WO2004110402A1 (pt) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2155205B1 (en) * | 2007-06-21 | 2011-12-21 | Pantarhei Bioscience B.V. | Treatment of meconium aspiration syndrome with estrogens |
| CN102202672A (zh) * | 2008-10-10 | 2011-09-28 | 达拉生物科学公司 | 使用穗霉素衍生物治疗或预防疼痛的方法 |
| US9034389B2 (en) * | 2009-03-11 | 2015-05-19 | Stable Solutions Llc | Omega-3 enriched fish oil-in-water parenteral nutrition emulsions |
| US8993625B2 (en) | 2009-03-11 | 2015-03-31 | Stable Solutions Llc | Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle |
| US20110200645A1 (en) * | 2010-02-18 | 2011-08-18 | Martek Biosciences Corporation | DHA Free Fatty Acid Emulsions |
| WO2011103510A1 (en) * | 2010-02-18 | 2011-08-25 | Martek Biosciences Corporation | Dha ester emulsions |
| US20110206741A1 (en) * | 2010-02-18 | 2011-08-25 | Martek Biosciences Corporation | DHA Triglyceride Emulsions |
| EP2544707B1 (en) * | 2010-03-09 | 2018-11-21 | Dignity Health | Methods for inhibiting preterm labor and uterine contractility disorders and preventing cervical ripening |
| TW201138782A (en) * | 2010-04-26 | 2011-11-16 | Besins Healthcare Lu Sarl | Low-oil pharmaceutical emulsion compositions comprising progestogen |
| EP2782584B1 (en) | 2011-11-23 | 2021-06-09 | TherapeuticsMD, Inc. | Natural combination hormone replacement formulations and therapies |
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| TW201334808A (zh) * | 2012-02-29 | 2013-09-01 | Braun Melsungen Ag | 含有荷爾蒙之包含磷蝦磷脂質的乳劑 |
| NO2819649T3 (pt) * | 2012-02-29 | 2018-06-09 | ||
| US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
| US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| AR100562A1 (es) | 2014-05-22 | 2016-10-12 | Therapeuticsmd Inc | Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal |
| WO2016044784A1 (en) | 2014-09-19 | 2016-03-24 | Heron Therapeutics, Inc. | Emulson formulations of aprepitant |
| US9974742B2 (en) | 2016-02-01 | 2018-05-22 | Heron Therapeutics, Inc. | Emulsion formulations of an NK-1 receptor antagonist and uses thereof |
| US10285998B1 (en) | 2018-04-04 | 2019-05-14 | The Menopause Method, Inc. | Composition and method to aid in hormone replacement therapy |
| US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60258110A (ja) * | 1984-06-05 | 1985-12-20 | Daigo Eiyou Kagaku Kk | 静脈注射可能なプロゲステロン乳化注射液 |
| CA2013755C (en) * | 1989-04-05 | 1993-11-30 | Simon Benita | Medicinal emulsions |
| CN1029293C (zh) * | 1993-01-01 | 1995-07-12 | 浙江省中医院 | 薏苡仁中性油脂乳剂 |
| SE9301171D0 (sv) * | 1993-04-07 | 1993-04-07 | Ab Astra | Pharmaceutical composition containing lipophilic drugs |
| US6267985B1 (en) * | 1999-06-30 | 2001-07-31 | Lipocine Inc. | Clear oil-containing pharmaceutical compositions |
| CN1204238C (zh) * | 2000-10-18 | 2005-06-01 | 李大鹏 | 从核桃仁中提取的核桃仁油组合物及其药物制剂 |
-
2003
- 2003-06-18 EP EP03013790A patent/EP1488785A1/de not_active Withdrawn
-
2004
- 2004-06-15 BR BRPI0410558-3A patent/BRPI0410558A/pt not_active Application Discontinuation
- 2004-06-15 PT PT04741802T patent/PT1633325E/pt unknown
- 2004-06-15 PL PL04741802T patent/PL1633325T3/pl unknown
- 2004-06-15 DE DE502004003483T patent/DE502004003483D1/de not_active Expired - Lifetime
- 2004-06-15 JP JP2006516152A patent/JP2006527736A/ja active Pending
- 2004-06-15 MX MXPA05012411A patent/MXPA05012411A/es active IP Right Grant
- 2004-06-15 EP EP04741802A patent/EP1633325B1/de not_active Expired - Lifetime
- 2004-06-15 RU RU2006101322/15A patent/RU2318494C2/ru active
- 2004-06-15 US US10/561,631 patent/US20070071777A1/en not_active Abandoned
- 2004-06-15 ES ES04741802T patent/ES2281813T3/es not_active Expired - Lifetime
- 2004-06-15 CN CN2004800170774A patent/CN1809339B/zh not_active Expired - Fee Related
- 2004-06-15 CA CA002526567A patent/CA2526567A1/en not_active Abandoned
- 2004-06-15 AT AT04741802T patent/ATE359061T1/de not_active IP Right Cessation
- 2004-06-15 WO PCT/EP2004/051114 patent/WO2004110402A1/de not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| ATE359061T1 (de) | 2007-05-15 |
| ES2281813T3 (es) | 2007-10-01 |
| CN1809339A (zh) | 2006-07-26 |
| RU2318494C2 (ru) | 2008-03-10 |
| PT1633325E (pt) | 2007-05-31 |
| WO2004110402A1 (de) | 2004-12-23 |
| CN1809339B (zh) | 2010-06-23 |
| EP1488785A1 (de) | 2004-12-22 |
| JP2006527736A (ja) | 2006-12-07 |
| EP1633325B1 (de) | 2007-04-11 |
| RU2006101322A (ru) | 2006-06-10 |
| CA2526567A1 (en) | 2004-12-23 |
| EP1633325A1 (de) | 2006-03-15 |
| DE502004003483D1 (de) | 2007-05-24 |
| MXPA05012411A (es) | 2006-02-13 |
| US20070071777A1 (en) | 2007-03-29 |
| AU2004246823A1 (en) | 2004-12-23 |
| PL1633325T3 (pl) | 2007-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE502004003483D1 (de) | Emulsion zur postnatalen hormonsubstitution | |
| ATE380541T1 (de) | Herstellung von vitaminemulsionen und konzentrate davon | |
| Wax et al. | Distribution and properties of beta-adrenergic receptors in human iris-ciliary body. | |
| Zhang et al. | Effects of gender and estradiol treatment on focal brain ischemia | |
| BR0111136A (pt) | Composição farmacêutica estéril, uso da mesma, e, método para melhorar a sobrevivência de um paciente doente em estado crìtico | |
| BR0107042A (pt) | Dispersões para a formulação de agentes fracamente ou ligeiramente solúveis | |
| ATE454885T1 (de) | Mikrosphären von estradiol und cholesterol | |
| BR112014020264A8 (pt) | Composição auxiliar de refluxo de microemulsão, método para aumentar a ecuperação de óleo ou gás durante processos de fraturamento ou estimulação e processo para aumentar refluxo a partir de uma formação de reservatório subterrânea | |
| ATE488240T1 (de) | Mittel zur behanldung von krankheiten zur aufbringung auf das auge | |
| DE69426320T2 (de) | Verwendung von silikon/fluorsilikon kopolymeröl zur herstellung eines arzneimittels zur behandlung von augenerkrankungen | |
| DE60123750D1 (de) | Nanopartikel mit verzögerter Freisetzung zur perkutanen Anwendung sowie diese enthaltende Zusammensetzung | |
| IL114212A (en) | Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same | |
| AR020811A1 (es) | Un procedimiento para producir una emulsion que contiene un antitranspirante, una emulsion antitranspirante y uso no terapeutico de la emulsion antitranspirante. | |
| ATE243995T1 (de) | Nanoemulsion von dem öl-in-wasser typ, gebrauchbar als ein ophthalmischen vehikel und verfahren zur seiner herstellung | |
| AR075437A1 (es) | Composicion inmunogenica que comprende al menos un antigeno del virus del dengue inactivado y un adyuvante sin aluminio, metodo para producir dicha vacuna y su uso para preparar un medicamento | |
| JP2006527736A5 (pt) | ||
| BRPI0415650A (pt) | composto anfifìlico e processo para preparação do mesmo | |
| KR960700039A (ko) | β-시클로덱스트린 유도체 및 탄산 탈수효소 저해제로 이루어진 안과용 국소 투여 조성물(Topical Compositions for the Eye Comprising a β-cyclodextrin Derivative and a Carbonic Anhydrase Inhibitor) | |
| DE602004018407D1 (de) | Kationische Verdickungsmittel, Verfahren zu deren Herstellung und diese enthaltende Zusammensetzung | |
| MX2022007095A (es) | Método para preparar formulación de emulsión de péptidos. | |
| Schmidt et al. | A modified technique to stain the internal limiting membrane with indocyanine green | |
| FR2852257B1 (fr) | Emulsions eau-dans-huile, a forte teneur en phase aqueuse, obtenues par un procede simple et economique | |
| Kapetanios et al. | Idiopathic giant retinal tears: treatment with vitrectomy and temporary silicone oil tamponade | |
| Seitz et al. | Immunological graft reactions after penetrating keratoplasty-A prospective randomized trial comparing corneal excimer laser and motor trephination | |
| NO20090035L (no) | Oralt innkapslet preparat for akvatiske dyr, fremgangsmate for fremstilling derav, og anvendelse derav |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B15K | Others concerning applications: alteration of classification |
Free format text: PARA: INT. CL. A61K 9/107, 31/565, 31/57; A61P 5/00, 25/00 Ipc: A61K 9/107 (2011.01), A61K 31/565 (2011.01), A61K |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |